Affiliation:
1. Marri Laxman Reddy Institute of Pharmacy, Hyderabad, India
2. College of Pharmaceutical Sciences, Dayananda Sagar
University, Bengaluru, India
Abstract
Abstract::
L-arginine is a semi-essential amino acid that plays a critical role in various physiological
processes, such as protein synthesis, wound healing, immune function, and cardiovascular regulation.
The use of L-arginine in pregnancy has been an emerging topic in the field of pharmacogenomics.
L-arginine, an amino acid, plays a crucial role in the production of nitric oxide, which is
necessary for proper placental development and fetal growth. Studies have shown that L-arginine
supplementation during pregnancy can have positive effects on fetal growth, maternal blood pressure,
and the prevention of preeclampsia. This emerging pharmacogenomic approach involves using
genetic information to personalize L-arginine dosages for pregnant women based on their specific
genetic makeup. By doing so, it may be possible to optimize the benefits of L-arginine supplementation
during pregnancy and improve pregnancy outcomes. This paper emphasizes the potential
applications of L-arginine in pregnancy and the use of pharmacogenomic approaches to enhance
its effectiveness. Nonetheless, the emerging pharmacogenomic approach to the application
of L-arginine offers exciting prospects for the development of novel therapies for a wide range of
diseases.
Publisher
Bentham Science Publishers Ltd.